Delivery Order SPE2DX15D9315-SPE2DX24FMGKF

Award Date 4/15/24
Potential Completion Date 4/16/24
Potential Value $1.9K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,892.90 contract is for the delivery of Nucala 100 mg/mL auto-injectors. This delivery order falls under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to military healthcare facilities. The...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,785.80 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, which has a completion date of March 21, 2024, is for the supply of NUCALA 100 MG/ML auto-injectors to support the medical needs of military personnel and their dependents. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $7,571.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group, is for the supply of Nucala 100 mg/mL auto-injectors to support the recurring medical supply needs of military health facilities worldwide. DMS...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,892.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA, valued up to $499,999,999, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order worth $106,002.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, placed under the DLA's SPE2DB Indefinite Delivery Contract (IDC), is for the delivery of NUCALA 100 MG/ML auto-injectors to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant IDC with the DLA, valued...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $7,571.60 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of the pharmaceutical product Nucala 100 mg/ml auto-injector. This order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, that covers a wide range of pharmaceutical items to support...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $3,785.80 contract is for the supply of NUCALA 100 MG/ML AUTO-INJECTOR medical products. This order is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $5,678.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 100 mg/mL Nucala auto-injectors and has an ultimate completion date of December 10, 2024. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) under the SPE2DB program, which enables the DLA to issue...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $11,357.40 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of NUCALA 100 MG/ML auto-injectors and has a period of performance through March 22, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract with DLA, valued at up to $4,999,999, which enables the agency to issue delivery orders for a broad range...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $26,500.60 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of the pharmaceutical product NUCALA 100 MG/ML AUTO-INJECTORML. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue delivery orders for a...
  • SPE2DX15D9315
    Indefinite Delivery Contract
  • SPE2DX15D9315-SPE2DX24FMGKF
    Delivery Order

The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,892.90 contract, with a completion date of April 16, 2024, is to provide the DLA's Medical Supply Chain division with 100 mg/mL Nucala auto-injectors. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, that allows the agency to issue delivery orders for a wide range of pharmaceutical products to support the medical needs of military healthcare facilities worldwide. This contract award does not have a set-aside designation.

Generated 7/15/24, 6:54 PM